🏛️ Verified NIH Record • Updated 2025-12-16
SyncAV Post-Market Trial (NCT04100148)
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Abbott Medical Devices
🩺 Plain-English Summary (8th-Grade Level)
The SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT through evaluation of changes in left ventricular (LV) reverse remodeling.
Who can join: Review the eligibility criteria below.
Location: Heart Center Research, LLC. — Huntsville, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (104 Sites)
Showing the first 25 of 104 sites.
- Heart Center Research, LLC. — Huntsville, Alabama
- Arizona Cardiovascular Research Center — Phoenix, Arizona
- HonorHealth — Scottsdale, Arizona
- Comprehensive Cardiovascular — Bakersfield, California
- Cardiovascular Consultants Heart Center — Fresno, California
- USC University Hospital — Los Angeles, California
- Colorado Heart & Vascular, P.C. — Lakewood, Colorado
- Shands at the University of Florida — Gainesville, Florida
- Heart Rhythm Solutions — Hollywood, Florida
- Piedmont Heart Institute — Atlanta, Georgia
- Emory University Hospital — Atlanta, Georgia
- Iowa Heart Center — West Des Moines, Iowa
- Baptist Health Lexington — Lexington, Kentucky
- Sparrow Clinical Research Institute — Lansing, Michigan
- Washington University School of Medicine — St Louis, Missouri
- Catholic Medical Center — Manchester, New Hampshire
- Deborah Heart & Lung Center — Browns Mills, New Jersey
- Cardiovascular Associates of the Delaware Valley — Haddon Heights, New Jersey
- Lourdes Cardiology Services — Voorhees Township, New Jersey
- New York Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York
- Cleveland Clinic Foundation — Cleveland, Ohio
- The Toledo Hospital — Toledo, Ohio
- Hightower Clinical — Oklahoma City, Oklahoma
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- Medical University of South Carolina — Charleston, South Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Congestive Heart Failure
- Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study — Boston, Massachusetts
- Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure — Birmingham, Alabama
- Boston Medical Center Ultrasound Decongestion Study in Heart Failure — Boston, Massachusetts
- Palliative Care for People With HF — Indianapolis, Indiana
- Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease — Murray, Utah
Explore by condition: All Congestive Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.